Literature DB >> 26202575

Genome-wide association study of IgA nephropathy using 23 465 microsatellite markers in a Japanese population.

Sanae Saka1,2, Nobuhito Hirawa2, Akira Oka3, Keisuke Yatsu1, Takeshi Hirukawa4, Ryohei Yamamoto5, Taiji Matsusaka4, Enyu Imai6,7, Ichiei Narita8, Masayuki Endoh4, Iekuni Ichikawa9,10, Satoshi Umemura1, Hidetoshi Inoko3.   

Abstract

Immunoglobulin A nephropathy (IgAN) is the most common form of primary glomerulonephritis in many parts of the world. Although previous genome-wide association studies (GWAS) identified the major susceptibility loci for IgAN, the causal genes currently remain unknown. We performed a GWAS using 23 465 microsatellite (MS) markers to identify genes related to IgAN in a Japanese population. A pooled sample analysis was conducted in three-stage screenings of three independent case-control populations, and after the final step of individual typing, 11 markers survived. Of these, we focused on two regions on 6p21 and 12q21 because they (i) showed the strongest relationship with IgAN, and (ii) appeared to be highly relevant to IgAN in view of several previous studies. These regions contained the HLA, TSPAN8 and PTPRR genes. This study on GWAS, using >20 000 MS markers, provides a new approach regarding susceptible genes for IgAN for investigators seeking new tools for the prevention and treatment of IgAN.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26202575     DOI: 10.1038/jhg.2015.88

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  31 in total

1.  Strategies for genome-wide association studies: optimization of study designs by the stepwise focusing method.

Authors:  Akira Saito; Naoyuki Kamatani
Journal:  J Hum Genet       Date:  2002       Impact factor: 3.172

Review 2.  Genetic studies of IgA nephropathy.

Authors:  Patrick H Maxwell; Yiming Wang
Journal:  Nephron Exp Nephrol       Date:  2005-11-11

3.  Whole genome association study of rheumatoid arthritis using 27 039 microsatellites.

Authors:  Gen Tamiya; Minori Shinya; Tadashi Imanishi; Tomoki Ikuta; Satoshi Makino; Koichi Okamoto; Koh Furugaki; Toshiko Matsumoto; Shuhei Mano; Satoshi Ando; Yasuyuki Nozaki; Wataru Yukawa; Ryo Nakashige; Daisuke Yamaguchi; Hideo Ishibashi; Manabu Yonekura; Yuu Nakami; Seiken Takayama; Takaho Endo; Takuya Saruwatari; Masaru Yagura; Yoko Yoshikawa; Kei Fujimoto; Akira Oka; Suenori Chiku; Samuel E V Linsen; Marius J Giphart; Jerzy K Kulski; Toru Fukazawa; Hiroshi Hashimoto; Minoru Kimura; Yuuichi Hoshina; Yasuo Suzuki; Tomomitsu Hotta; Joji Mochida; Takatoshi Minezaki; Koichiro Komai; Shunichi Shiozawa; Atsuo Taniguchi; Hisashi Yamanaka; Naoyuki Kamatani; Takashi Gojobori; Seiamak Bahram; Hidetoshi Inoko
Journal:  Hum Mol Genet       Date:  2005-07-06       Impact factor: 6.150

Review 4.  Tetraspanins: push and pull in suppressing and promoting metastasis.

Authors:  Margot Zöller
Journal:  Nat Rev Cancer       Date:  2008-12-11       Impact factor: 60.716

Review 5.  Evidence for genetic factors in the development and progression of IgA nephropathy.

Authors:  S I Hsu; S B Ramirez; M P Winn; J V Bonventre; W F Owen
Journal:  Kidney Int       Date:  2000-05       Impact factor: 10.612

6.  IGA nephropathy in HLA-identical siblings.

Authors:  N E Tolkoff-Rubin; A B Cosimi; T Fuller; R H Rublin; R B Colvin
Journal:  Transplantation       Date:  1978-12       Impact factor: 4.939

7.  Localization of a non-melanoma skin cancer susceptibility region within the major histocompatibility complex by association analysis using microsatellite markers.

Authors:  A Oka; H Hayashi; M Tomizawa; K Okamoto; L Suyun; J Hui; J K Kulski; J Beilby; G Tamiya; H Inoko
Journal:  Tissue Antigens       Date:  2003-03

Review 8.  The genetics of IgA nephropathy.

Authors:  Isabel Beerman; Jan Novak; Robert J Wyatt; Bruce A Julian; Ali G Gharavi
Journal:  Nat Clin Pract Nephrol       Date:  2007-06

9.  HLA class II typing and idiopathic IgA nephropathy (IgAN): DQB1*0301, a possible marker of unfavorable outcome.

Authors:  O Raguénès; B Mercier; J Clèdes; B Whebe; C Férec
Journal:  Tissue Antigens       Date:  1995-04

10.  An extended association screen in multiple sclerosis using 202 microsatellite markers targeting apoptosis-related genes does not reveal new predisposing factors.

Authors:  René Gödde; Stefanie Brune; Peter Jagiello; Eckhart Sindern; Michael Haupts; Sebastian Schimrigk; Norbert Müller; Jörg T Epplen
Journal:  J Negat Results Biomed       Date:  2005-09-05
View more
  6 in total

1.  Epigenome-wide association study and network analysis for IgA Nephropathy from CD19+ B-cell in Chinese Population.

Authors:  Yifei Lin; Peiran Yin; Zhaozhong Zhu; Yuan Peng; Ming Li; Jun Li; Liming Liang; Xueqing Yu
Journal:  Epigenetics       Date:  2021-01-07       Impact factor: 4.528

Review 2.  Aberrant IgA1 Glycosylation in IgA Nephropathy: A Systematic Review.

Authors:  Qiang Sun; Zhenhai Zhang; Hong Zhang; Xiaorong Liu
Journal:  PLoS One       Date:  2016-11-21       Impact factor: 3.240

Review 3.  The Role of IgA in the Pathogenesis of IgA Nephropathy.

Authors:  Martina Perše; Željka Večerić-Haler
Journal:  Int J Mol Sci       Date:  2019-12-09       Impact factor: 5.923

4.  Increased Lifetime Risk of ESRD in Familial IgA Nephropathy.

Authors:  Manman Shi; Shuwen Yu; Yan Ouyang; Yuanmeng Jin; Zijin Chen; Wenjie Wei; Zhengying Fang; Wen Du; Zhaohui Wang; Qinjie Weng; Jun Tong; Xiaoxia Pan; Weiming Wang; Kiryluk Krzysztof; Nan Chen; Jingyuan Xie
Journal:  Kidney Int Rep       Date:  2020-10-20

5.  IgA1 Glycosylation Is Heritable in Healthy Twins.

Authors:  Hannah J Lomax-Browne; Alessia Visconti; Charles D Pusey; H Terence Cook; Tim D Spector; Matthew C Pickering; Mario Falchi
Journal:  J Am Soc Nephrol       Date:  2016-06-16       Impact factor: 10.121

6.  The influence of environmental factors on clinical pathological changes of patients with immunoglobulin A nephropathy from different areas of China.

Authors:  Ping Fan; Jianmin Song; Qun Chen; Xiaohong Cheng; Xusheng Liu; Chuan Zou; Bin Xie
Journal:  Ren Fail       Date:  2018-11       Impact factor: 2.606

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.